Investigator
Kent State University
Visible light-activatable platinum(iv) prodrugs harnessing CD36 for ovarian cancer therapy
Visible light-activatable Pt(iv) prodrugs harness the upregulated CD36 to facilitate cell entry and killing of drug resistant ovarian cancer cells.
